Extended Support for Persons With Pituitary Tumours After Surgery
NCT03927183 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86
Last updated 2025-04-06
Summary
Patients with pituitary tumours often live with life-long consequences of their disease. Treatment options include surgery, radiotherapy and medical therapy. Symptoms associated with the tumour and/or its treatment affects several areas of life. The year after pituitary surgery constitutes an important time-period with medical evaluations of surgery and decisions on hormonal substitution. The development and evaluation of extended patient support during this time-point is limited. Care based on person-centredness has exclusively been promoted which comprises a care where care providers inquire how patients view their health situation and what their needs, resources, and preferences are. Person-centredness focuses on preserving patient autonomy, function, and well-being and strives to emphasize patient involvement through equalizing power between health care professionals and the patient with the main goal of an enhanced health situation. The aim of the study is to evaluate if a support within a person-centered care practice one year after surgery increases wellbeing for patients with pituitary tumours.
Conditions
- Pituitary Tumor Benign
- Surgery
Interventions
- OTHER
-
person-centred practice
The structure and content of the intervention is constructed on principles for person-centredness. Each patients in the intervention are allocated a hospital-initiated nurse care manager during one year after surgery. Self-management support is primarily conducted between the patient and the nurse care manager. The primary goal of the support is to facilitate patients own resources in managing illness and health education on e.g. physical activity and diet. The support also comprises patient-held documentation and health plan. Other components of the intervention comprise accessibility and continuity which is secured by a structured clinical care pathway with planned care and defined care contacts. The patient has continuous access to the nurse care manager by telephone and face-to-face contact according to a structured follow-up plan. An interdisciplinary team as well as a patient education program constitutes distinct parts of the support during the year after surgery.
Sponsors & Collaborators
-
Göteborg University
lead OTHER
Principal Investigators
-
Eva Jakobsson Ung, professor · Göteborg University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-06
- Primary Completion
- 2022-02-28
- Completion
- 2022-02-28
Countries
- Sweden
Study Locations
More Related Trials
-
Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection
NCT03933241 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields
NCT03501134 ·Status: COMPLETED
-
Hypofractionated Radiotherapy
NCT06740955 ·Status: RECRUITING ·Phase: NA
-
Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain
NCT06287515 ·Status: RECRUITING ·Phase: PHASE1
-
Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
NCT03997136 ·Status: UNKNOWN
-
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
NCT07015645 ·Status: COMPLETED
-
Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma
NCT04573816 ·Status: UNKNOWN
-
GROW (Glioma Specialists Reaching Out With Support) Support
NCT05233215 ·Status: WITHDRAWN ·Phase: NA
-
Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children
NCT01635140 ·Status: COMPLETED ·Phase: PHASE3
-
Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment
NCT02996734 ·Status: COMPLETED
-
Prospective Study on Quality of Life in Patients With Intracranial Germ Cell Tumors
NCT05124964 ·Status: RECRUITING
-
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
NCT03903419 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors
NCT05124951 ·Status: RECRUITING ·Phase: PHASE2
-
Brain Tumor Treatment Satisfaction Survey
NCT00557375 ·Status: COMPLETED
-
Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence
NCT05071001 ·Status: COMPLETED ·Phase: NA
-
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
NCT02854228 ·Status: UNKNOWN
-
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
NCT05486923 ·Status: COMPLETED
-
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
NCT06014398 ·Status: UNKNOWN ·Phase: NA
-
Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)
NCT06826170 ·Status: COMPLETED ·Phase: NA
-
Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions
NCT06705036 ·Status: RECRUITING
-
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
NCT03678389 ·Status: RECRUITING ·Phase: NA
-
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 ·Status: RECRUITING
-
Quality of Life and Patient Needs in Advanced High Grade Gliomas
NCT05039346 ·Status: COMPLETED
-
A Family Study of Adults With Glioma
NCT00339352 ·Status: COMPLETED
-
The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
NCT01377701 ·Status: UNKNOWN